cannaworld001016.jpg cannaworld001014.jpg cannaworld001012.jpg cannaworld001010.jpg cannaworld001006.jpg cannaworld001004.jpg cannaworld001003.jpg cannaworld010004.jpg
Glioblastoma multiforme
 
GBM, also known as glioblastoma and grade IV astrocytoma, is the most common and most aggressive malignant primary brain tumor. It involves glial cells and accounting for 52% of all brain tissue tumor cases and 20% of all tumors inside the skull. GBM is a rare disease, with a rate of 2–3 cases per 100,000 person life-years in Europe and North America. About 50% of the people diagnosed with GBM die within one year, while 90% within three years.
 
Bron: WIKIPEDIA
A pilot clinical study of delta 9 -tetrahydrocannabinol in patients with recurrent glioblastoma multiforme (pdf)
Wetenshap GBM en cannabinoïden
Cannabis Treatment For Brain Cancer Begins First Human Trials
cannaworld001008.jpg